Pyridoxal-5′-phosphate deficiency after intestinal and multivisceral transplantation

American Journal of Clinical Nutrition

Volumn 89, Issue 1, 2009, Pages 204-209

  Matarese, Laura E ^a   Dvorchik, Igor ^a   Costa, Guilherme ^a   Bond, Geoffrey J ^a   Koritsky, Darlene A ^a   Ferraris, Ronaldo P ^b   Touger Decker, Riva ^b   O'Sullivan Maillet, Julie K ^b   Abu Elmagd, Kareem M ^a,c  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; PYRIDOXAL 5 PHOSPHATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENTERIC FEEDING; FEMALE; GRAFT RECIPIENT; HUMAN; INCIDENCE; INTESTINE GRAFT; MALE; ORGAN TRANSPLANTATION; PARENTERAL NUTRITION; PROSPECTIVE STUDY; PYRIDOXAL 5 PHOSPHATE DEFICIENCY; RISK FACTOR; SHORT BOWEL SYNDROME; VITAMIN BLOOD LEVEL; VITAMIN DEFICIENCY; BLOOD; ENTEROPATHY; INTESTINE; LIVER TRANSPLANTATION; MIDDLE AGED; NUTRITIONAL STATUS; PANCREAS TRANSPLANTATION; PYRIDOXINE DEFICIENCY; STOMACH; TIME; TRANSPLANTATION;

ADULT; AGED; ENTERAL NUTRITION; FEMALE; HOMOCYSTEINE; HUMANS; INCIDENCE; INTESTINAL DISEASES; INTESTINES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PANCREAS TRANSPLANTATION; PARENTERAL NUTRITION; PROSPECTIVE STUDIES; PYRIDOXAL PHOSPHATE; RISK FACTORS; STOMACH; TIME FACTORS; VITAMIN B 6 DEFICIENCY; YOUNG ADULT;

EID: 58149375667     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.3945/ajcn.2008.26898     Document Type: Article

References (36)

1. Abu-Elmagd K, Bond G, Reyes J, Fung J. Intestinal transplantation: a coming of age. Adv Surg 2002;36:65-101.
2. Abu-Elmagd K, Reyes J, Todo S, et al. Clinical intestinal transplantation: new perspectives and immunologic considerations. JAm Coll Surg 1998;186:512-25.
3. Reyes J, Bueno J, Kocoshis S, et al. Current status of intestinal transplantation in children. J Pediatr Surg 1998;33:243-54.
4. Grant D, Abu-Elmagd K, Reyes J, et al. 2003 Report of the Intestine Transplant Registry: a new era has dawned. Ann Surg 2005;241:607-13.
5. Abu-Elmagd K, Reyes J, Bond G, et al. Clinical intestinal transplantation: a decade of experience at a single center. Ann Surg 2001;234:404-16 (discussion 416-07).
6. Matarese L, Martin L, Koritsky D, et al. Vitamin B6 status after intestinal and multivisceral transplantation in adults. European Society for Clinical Nutrition and Metabolism, 2006; P0159:97.
7. Starzl TE, Murase N, Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet 2003;361:1502-10.
8. Institute of Medicine. Dietary reference intakes. Washington, DC: The National Academies Press, 2006.
9. Rybak ME, Jain RB, Pfeiffer CM. Clinical vitamin B6 analysis: an interlaboratory comparison of pyridoxal 5′-phosphate measurements in serum. Clin Chem 2005;51:1223-31.
10. Shin YS, Rasshofer R, Friedrich B, Endres W. Pyridoxal-5′-phosphate determination by a sensitive micromethod in human blood, urine and tissues; its relation to cystathioninuria in neuroblastoma and biliary atresia. Clin Chim Acta 1983;127:77-85.
11. Giannetti N, Herity NA, Alimollah A, et al. Mild hyperhomocysteinemia is not associated with cardiac allograft coronary disease. Clin Transplant 2001;15:247-52.
12. Gupta A, Moustapha A, Jacobsen DW, et al. High homocysteine, low folate, and low vitamin B6 concentrations: prevalent risk factors for vascular disease in heart transplant recipients. Transplantation 1998;65:544-50.
13. Kutschka I, Pethig K, Struber M, Dieterich C, Harringer W, Haverich A. Homocysteine - a treatable risk factor for allograft vascular disease after heart transplantation? J Heart Lung Transplant 2001;20:743-6.
14. Lacour B, Parry C, Drueke T, et al. Pyridoxal 5′-phosphate deficiency in uremic undialyzed, hemodialyzed, and non-uremic kidney transplant patients. Clin Chim Acta 1983;127:205-15.
15. Mitwalli A, Oreopoulos DG. Hyperoxaluria and hyperoxalemia: one more concern for the nephrologist. Int J Artif Organs 1985;8:71-4.
16. van Guldener C, Robinson K. Homocysteine and renal disease. Semin Thromb Hemost 2000;26:313-24.
17. Tewari PC, Zhang B, Bluestein BI. Analytical and clinical evaluation of the Bayer ADVIA Centaur homocysteine assay. Clin Chim Acta 2004;342:171-8.
18. Rovera GM, Schoen RE, Goldbach B, et al. Intestinal and multivisceral transplantation: dynamics of nutritional management and functional autonomy. JPEN J Parenter Enteral Nutr 2003;27:252-9.
19. Matarese LE, Costa G, Bond G, et al. Therapeutic efficacy of intestinal and multivisceral transplantation: survival and nutrition outcome. Nutr Clin Pract 2007;22:474-81.
20. Abu-Elmagd K, Fung JJ, Reyes J, et al. Management of intestinal transplantation in humans. Transplant Proc 1992;24:1243-4.
21. Rovera GM, Strohm S, Bueno J, et al. Nutritional monitoring of pediatric intestinal transplant recipients. Transplant Proc 1998;30:2519-20.
22. Kaufman SS, Lyden ER, Brown CR, et al. Disaccharidase activities and fat assimilation in pediatric patients after intestinal transplantation. Transplantation 2000;69:362-5.
23. Mikalunas V, Fitzgerald K, Rubin H, McCarthy R, Craig RM. Abnormal vitamin levels in patients receiving home total parenteral nutrition. J Clin Gastroenterol 2001;33:393-6.
24. Lee RG, Nakamura K, Tsamandas AC, et al. Pathology of human intestinal transplantation. Gastroenterology 1996;110:1820-34.
25. Coburn SP, Lewis DL, Fink WJ, Mahuren JD, Schaltenbrand WE, Costill DL. Human vitamin B-6 pools estimated through muscle biopsies. Am J Clin Nutr 1988;48:291-4.
26. Abu-Elmagd K, Todo S, Tzakis A, et al. Intestinal transplantation and bacterial overgrowth in humans. Transplant Proc 1994;26:1684-5.
27. Browne BJ, Johnson CP, Edmiston CE, et al. Small bowel transplantation promotes bacterial overgrowth and translocation. J Surg Res 1991;51:512-7.
28. Cicalese L, Sileri P, Green M, Abu-Elmagd K, Kocoshis S, Reyes J. Bacterial translocation in clinical intestinal transplantation. Transplantation 2001;71:1414-7.
29. Shah SM, Roberts PJ, Watson CJ, et al. Relapsing encephalopathy following small bowel transplantation. Transplant Proc 2003;35:1565-6.
30. Mackey AD, McMahon RJ, Townsend JH, Gregory JF III. Uptake, hydrolysis, and metabolism of pyridoxine-5′-beta-D-glucoside in Caco-2 cells. J Nutr 2004;134:842-6.
31. Said HM, Ortiz A, Ma TY. A carrier-mediated mechanism for pyridoxine uptake by human intestinal epithelial Caco-2 cells: regulation by a PKA-mediated pathway. Am J Physiol Cell Physiol 2003;285:C1219-25.
32. Stolz J, Vielreicher M. Tpn1p, the plasma membrane vitamin B6 transporter of Saccharomyces cerevisiae. J Biol Chem 2003;278:18990-6.
33. Sweetman S. Martindale: the complete drug reference. 34th ed. Chicago, IL: Pharmaceutical Press, 2004.
34. Nahlawi M, Seshadri N, Boparai N, et al. Usefulness of plasma vitamin B6, B12, folate, homocysteine, and creatinine in predicting outcomes in heart transplant recipients. Am J Cardiol 2002;89:834-7.
35. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277:1775-81.
36. Kozik A, McCormick DB. Mechanism of pyridoxine uptake by isolated rat liver cells. Arch Biochem Biophys 1984;229:187-93.